Showing results (331-340 of 378) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trialV Georgoulias, C Kouroussis, N Androulakis, et al.
Oncology|June 6, 2000
Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experienceD Pectasides, T Economopoulos, G Kouvatseas, et al.
British Journal of Haematology|October 6, 2004
A phase 2 study of two doses of bortezomib in relapsed or refractory myelomaS Jagannath, B Barlogie, J Berenson, et al.
Gynecologic Oncology|April 17, 2007
Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistanceA Bamias, M L Tsiatas, E Kafantari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) studyG Aravantinos, G Fountzilas, P Kosmidis, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 1999
Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteriaC S Ha, V Kavadi, M A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemiaM A Dimopoulos, G Hamilos, K Zervas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2007
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology GroupP A Kosmidis, H P Kalofonos, C Christodoulou, et al.
Blood Cancer Journal|October 8, 2016
High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomatic multiple myelomaE Terpos, D Christoulas, E Kastritis, et al.
Leukemia|February 20, 2009
Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG)E Kastritis, K Zervas, A Symeonidis, et al.
Pageof 38